Fort Washington Investment Advisors Inc Jazz Pharmaceuticals PLC Transaction History

Fort Washington Investment Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$133.98 - $160.47 $210,482 - $252,098	1,571 New	1,571 $229,000
Q2 2022 Aug 05, 2022	SELL	$141.59 - $168.66 $5,946 - $7,083	-42 Reduced 2.29%	1,790 $279,000
Q1 2022 May 03, 2022	BUY	$129.64 - $160.7 $237,500 - $294,402	1,832 New	1,832 $285,000
Q3 2021 Nov 09, 2021	SELL	$128.64 - $184.79 $155,911 - $223,965	-1,212 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$160.2 - $186.42 $194,162 - $225,941	1,212 New	1,212 $215,000
Q1 2021 May 05, 2021	SELL	$150.19 - $173.5 $185,034 - $213,752	-1,232 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$140.71 - $165.05 $173,354 - $203,341	1,232 New	1,232 $203,000
Q3 2017 Nov 13, 2017	SELL	$142.62 - $155.6 $330,307 - $360,369	-2,316 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	2,316	2,316 $360,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.